SMEInst-03-2016-2017
SMEInst-03-2016-2017
38 projects · €17,813,501 total EU contribution (project-level) · 39 participating organizations · 13 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€17,813,501
Countries active
Participant organizations by country (headquarters in CORDIS).
- SE (7)
- France (5)
- Netherlands (5)
- Italy (4)
- Germany (3)
- IL (3)
- UK (3)
- DK (2)
- Spain (2)
- PL (2)
- CH (1)
- LU (1)
- LV (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ABICH1 projects · IT
- Access for Life1 projects · IL
- Alzinova AB1 projects · SE
- BBH BIOTECH1 projects · PL
- BETAGENON1 projects · SE
- BIOTICA1 projects · ES
- BRAINGINEERING1 projects · LU
- Cergentis B.V.1 projects · NL
- COLUMBIA SRL1 projects · IT
- CORNEA PROJECT1 projects · ES
- Cristal1 projects · NL
- DC4U1 projects · NL
Projects
Page 3 of 4
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease IMMOVA · 773570 | H2020 | €50,000 | €71,429 | Details |
Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer INTACT · 784127 | H2020 | €2,499,999 | €5,818,517 | Details |
A big jump in preventing problems in refractive surgery for myopia KERASTOP · 775591 | H2020 | €50,000 | €71,429 | Details |
Ultra Legionella Inmunoanalysis System for Early Sensing ULISENS · 726499 | H2020 | €768,929 | €1,098,470 | Details |
A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses MIMESIS · 739086 | H2020 | €2,498,229 | €3,568,899 | Details |
Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir THUNDER · 762583 | H2020 | €50,000 | €71,429 | Details |
Automatic Control of Blood Glucose Concentration for Intensive Care patients GLUCOSTAT · 777691 | H2020 | €2,499,796 | €3,571,138 | Details |
A new hope for early gonarthrosis treatment using a biotechnological therapeutic drug to regenerate cartilage by intra-articular knee injection RHYP · 766606 | H2020 | €2,105,950 | €3,008,500 | Details |
Demonstration of a synthetic biology-driven biomanufacturing platform for adaptable cost-effective production of high-value low volume biologics opportunities. SYNBIOMAN · 736304 | H2020 | €50,000 | €71,429 | Details |
IN-OVO AUTOMATION FOR CANCER DRUG DISCOVERY OVOMATIC · 744320 | H2020 | €50,000 | €71,429 | Details |